Your browser doesn't support javascript.
loading
Trabectedin in the treatment of metastatic soft-tissue sarcoma: cost-effectiveness and cost-utility are yet to be proved.
Blomqvist, C; Johansson, R; Tarkkanen, M.
Affiliation
  • Blomqvist C; Department of Oncology, Helsinki University Central Hospital, Helsinki.
  • Johansson R; Department of Oncology, Kuopio University Hospital, Kuopio, Finland.
  • Tarkkanen M; Department of Oncology, Helsinki University Central Hospital, Helsinki. Electronic address: maija.tarkkanen@hus.fi.
Ann Oncol ; 22(4): 988, 2011 Apr.
Article in En | MEDLINE | ID: mdl-21345940
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Antineoplastic Agents, Alkylating / Tetrahydroisoquinolines / Dioxoles Type of study: Health_economic_evaluation Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2011 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Antineoplastic Agents, Alkylating / Tetrahydroisoquinolines / Dioxoles Type of study: Health_economic_evaluation Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2011 Document type: Article